Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate is a chemical compound characterized by its molecular formula C17H21NO3. It is a white crystalline powder with a molecular weight of 287.35 g/mol. Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate is widely recognized for its role in organic synthesis and as a key intermediate in the production of pharmaceuticals and agrochemicals. Its potential as a building block in the synthesis of various bioactive compounds underscores its value within the pharmaceutical industry. However, it is crucial to handle this compound with care due to potential health hazards if not used properly.

156779-11-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 156779-11-2 Structure
  • Basic information

    1. Product Name: Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate
    2. Synonyms: Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate;6-oxo-1-(phenylmethyl)-3-Piperidinecarboxylic acid methyl ester
    3. CAS NO:156779-11-2
    4. Molecular Formula: C14H17NO3
    5. Molecular Weight: 247.28968
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 156779-11-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate(156779-11-2)
    11. EPA Substance Registry System: Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate(156779-11-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 156779-11-2(Hazardous Substances Data)

156779-11-2 Usage

Uses

Used in Pharmaceutical Industry:
Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate is used as a key intermediate for the synthesis of various pharmaceuticals. Its role in the creation of bioactive compounds makes it an essential component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective and innovative products for agricultural applications.
Organic Synthesis:
Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate is used as a building block in organic synthesis, facilitating the creation of a range of chemical compounds with diverse applications across various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 156779-11-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,7,7 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 156779-11:
(8*1)+(7*5)+(6*6)+(5*7)+(4*7)+(3*9)+(2*1)+(1*1)=172
172 % 10 = 2
So 156779-11-2 is a valid CAS Registry Number.

156779-11-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 1-Benzyl-6-oxopiperidine-3-carboxylate

1.2 Other means of identification

Product number -
Other names Methyl 1-benzyl-6-oxopiperidine-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:156779-11-2 SDS

156779-11-2Relevant articles and documents

ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

-

Page/Page column 453; 454, (2018/09/21)

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

ANGIOTENSIN-(1-7) ANALOGS AND METHODS RELATING THERETO

-

Paragraph 0143, (2017/07/06)

Angiotensin (1-7) analogs are provided. The analogs contain one or more substitutions with non-natural amino acid cis-3-(aminomethyl)cyclobutanecarboxylic acid (ACCA). Also provided are methods of making such analogs and methods for using such analogs as

Synthesis and reduction reactions of pyridones and 5-acyl-2-methoxypyridines

Bisset, Alexander A.,Dishington, Allan,Jones, Teyrnon,Clarkson, Guy J.,Wills, Martin

, p. 7207 - 7220 (2017/09/12)

The synthesis of a series of pyridones, from their 2-hydroxypyridine or 2-methoxypyridine precursors, is described, along with studies into their reductions to saturated heterocycles. A number of 5-acylpyridones were prepared and were evaluated as substrates for asymmetric transfer hydrogenation prior to conversion to saturated heterocycles. The enantioselective reduction of 5-acetyl-1-benzylpyrimidine-2,4(1H,3H)-dione is also described.

Synthesis of a conformationally constrained δ-amino acid building block

O'Reilly, Elaine,Pes, Lara,Ortin, Yannick,Mueller-Bunz, Helge,Paradisi, Francesca

, p. 511 - 518 (2013/07/27)

Conformationally restricted amino acids are important components in peptidomimetics and drug design. Herein, we describe the synthesis of a novel, non-proteinogenic constrained delta amino acid containing a cyclobutane ring, cis-3(aminomethyl)cyclobutane

An efficient synthetic route to functionalized δ-lactams

Samarat, Ali,Ben Kra?em, Jihène,Ben Ayed, Ta?cir,Amri, Hassen

, p. 9540 - 9543 (2008/12/22)

This paper describes a convenient synthesis of disubstituted functionalized δ-lactams based on Michael addition of primary amines to dimethyl-E-2-alkylidene glutarates 2 followed by an intramolecular cyclisation.

A flexible strategy for the synthesis of tri- and tetracyclic lupin alkaloids: Synthesis of (+)-cytisine, (±)-anagyrine, and (±)-thermopsine

Gray, Diane,Gallagher, Timothy

, p. 2419 - 2423 (2007/10/03)

(Chemical Equation Presented) Looping the lupin: A general synthetic strategy for the construction of the lupin alkaloids has been defined and involves sequential formation of the N1-C10 and C6-C7 bonds, which are common to compounds of this class of natu

A short synthesis of (±)-cytisine

Botuha, Candice,Galley, Carl M. S.,Gallagher, Timothy

, p. 1825 - 1826 (2007/10/03)

The synthesis of racemic cytisine 1 has been completed using (i) N-selective alkylation of 6-bromopyridone with bromide 6 and (ii) Pd(o) mediated intramolecular a-arylation of lactam 8 as key steps to achieve rapid assembly of the tricyclic core skeleton of the lupin alkaloids.

Construction of Hydroxylated Alkaloids (+/-)-Mannonolactam, (+/-)-Deoxymannojirimycin, and (+/-)-Prosopinine through Aza-Annulation

Cook, Gregory R.,Beholz, Lars G.,Stille, John R.

, p. 3575 - 3584 (2007/10/02)

The aza-annulation of β-enamino carbonyl substrates with acrylate derivatives provides an efficient and convenient route for the regioselective construction of δ-lactams.This two-step ring-forming sequence involved initial generation of the benzyl enamine through either a condensation or conjugate addition reaction with BnNH2, followed by aza-annulation with acryloyl chloride or acrylic anhydride.Controlled by the rigid framework of the intermediate lactam, introduction of ring substituents was accomplished with high relative stereoselectivity.The carbonyl functionality, which was necessary to direct the regioselectivity of the aza-annulation reaction, was then transformed into a protected hydroxyl substituent through Baeyer-Villiger oxidation.The resultant δ-lactam product was used as a valuable intermediate in the synthesis of three natural products.Subsequent modification of this δ-lactam gave the naturally occurring α-mannosidase inhibitors (+/-)-mannonolactam and (+/-)-deoxymannojirimycin, while synthesis of the alkaloid (+/-)-prosopinine was accomplished through homologation of the lactam carbonyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 156779-11-2